Literature DB >> 229725

Solid and mucinous varieties of so-called mammary carcinoid tumors.

E R Fisher, A S Palekar.   

Abstract

Three neoplasms that had histologic features reminiscent of carcinoid tumors of other sites were encountered in a review of 3,300 examples of invasive mammary cancer in women (.09%). One of these showed cytoplasmic argyrophilia. This, as well as the two putative carcinoids, lacked argentaffinity. Attention is directed to the occurence of variable numbers of argyrophilic cells in eight of 19 so-called mucinous cancers of the breast studied. Further, neurosecretory-type granules were observed in cells of all four mucinous cancers suitably prepared for electron microscopic examination. The possible reasons for the lack of universal argyrophilic reactions in these lesions is discussed. It is concluded that there may be two types of mammary carcinoid tumors, the solid and mucinous varieties. No patient who had the latter type had experienced treatment failure after five years of observation. Various numbers of ductal epithelial cells in four of 45 examples of banal fibrocystic disease showed cytoplasmic argyrophilia, and neurosecretory-type granules were found in two of eight examples suitably prepared for electron microscopic examination. Whether this demonstration establishes the existence of precursor elements for the development of the carcinoid tumors is at present uncertain.

Entities:  

Mesh:

Year:  1979        PMID: 229725     DOI: 10.1093/ajcp/72.6.909

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  12 in total

1.  Endocrine variant of ductal carcinoma in situ of breast: ultrastructural and light microscopical study.

Authors:  M T Ashworth; M T Haqqani
Journal:  J Clin Pathol       Date:  1986-12       Impact factor: 3.411

Review 2.  [Neuroendocrine neoplasms of the breast].

Authors:  M Anlauf; M Neumann; S Bomberg; K Luczak; S Heikaus; C Gustmann; C Antke; S Ezziddin; C Fottner; M Pavel; U-F Pape; A Rinke; H Lahner; M Schott; B Cremer; D Hörsch; R P Baum; U Groh; I Alkatout; C Rudlowski; P Scheler; T K Zirbes; J Hoffmann; T Fehm; H E Gabbert; S E Baldus
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

3.  The significance of argyrophilia in human breast carcinomas.

Authors:  J McCutcheon; R A Walker
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

4.  A case of primary neuroendocrine breast carcinoma that responded to neo-adjuvant chemotherapy.

Authors:  Xiaolong Wei; Chunfa Chen; Didi Xi; Jinwen Bai; Wenhe Huang; Luoxiang Rong; Mingyao Wu; Guojun Zhang
Journal:  Front Med       Date:  2014-08-06       Impact factor: 4.592

5.  Small cell neuroendocrine (oat cell) carcinoma of the male breast. Immunocytochemical and ultrastructural investigations.

Authors:  G Jundt; A Schulz; P U Heitz; M Osborn
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

Review 6.  Carcinomas of the breast with endocrine differentiation: a review.

Authors:  H M Maluf; F C Koerner
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  Chromogranin A and B gene expression in carcinomas of the breast. Correlation of immunocytochemical, immunoblot, and hybridization analyses.

Authors:  A Pagani; M Papotti; H Höfler; R Weiler; H Winkler; G Bussolati
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

8.  Chromogranin-reactive endocrine cells in argyrophilic carcinomas ("carcinoids") and normal tissue of the breast.

Authors:  G Bussolati; P Gugliotta; A Sapino; V Eusebi; R V Lloyd
Journal:  Am J Pathol       Date:  1985-08       Impact factor: 4.307

9.  Primary oat cell (neuroendocrine) carcinoma of the breast. Report of four cases.

Authors:  M Papotti; G Gherardi; V Eusebi; A Pagani; G Bussolati
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

10.  Mucinous carcinoma of breast: Cytodiagnosis of a case.

Authors:  Sangeeta Sharma; Rani Bansal; Anjali Khare; Nivesh Agrawal
Journal:  J Cytol       Date:  2011-01       Impact factor: 1.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.